Development of a novel cancer therapy targeting protein modifications in the tumor microenvironment

• Forschungsstelle: INNOSUISSE
• Projektnummer: 40143.1 IP-LS
• Projekttitel Englisch: Development of a novel cancer therapy targeting protein modifications in the tumor microenvironment

Kurzbeschreibung (Deutsch)

Development of a novel cancer therapy targeting protein modifications in the tumor microenvironment

Kurzbeschreibung (Englisch)

Development of a novel cancer therapy targeting protein modifications in the tumor microenvironment

Abstract (Deutsch)

We are developing a monoclonal antibody-based therapy against a novel target that is upregulated in many solid tumors. With this project, we will generate the proof-of-concept that the therapy will work in preclinical in vivo tumor models.